Dose intensity in poor risk lymphomas: a critical factor in LNH-87 protocol?
Lepage
E
E
Département de Biostatistique et d'Informatique Médicale, Hôpital Saint-Louis, Paris, France.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*